<code id='C3C9A5B4BD'></code><style id='C3C9A5B4BD'></style>
    • <acronym id='C3C9A5B4BD'></acronym>
      <center id='C3C9A5B4BD'><center id='C3C9A5B4BD'><tfoot id='C3C9A5B4BD'></tfoot></center><abbr id='C3C9A5B4BD'><dir id='C3C9A5B4BD'><tfoot id='C3C9A5B4BD'></tfoot><noframes id='C3C9A5B4BD'>

    • <optgroup id='C3C9A5B4BD'><strike id='C3C9A5B4BD'><sup id='C3C9A5B4BD'></sup></strike><code id='C3C9A5B4BD'></code></optgroup>
        1. <b id='C3C9A5B4BD'><label id='C3C9A5B4BD'><select id='C3C9A5B4BD'><dt id='C3C9A5B4BD'><span id='C3C9A5B4BD'></span></dt></select></label></b><u id='C3C9A5B4BD'></u>
          <i id='C3C9A5B4BD'><strike id='C3C9A5B4BD'><tt id='C3C9A5B4BD'><pre id='C3C9A5B4BD'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:41489
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Novo Nordisk touts Wegovy study, but still struggling with supply
          Novo Nordisk touts Wegovy study, but still struggling with supply

          LISELOTTESABROE/Scanpix/AFPviaGettyImagesThereleaseofNovoNordisk’slatestearningsreportonThursdayprov

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Childhood vaccination ad campaign launches in the U.K.

          AyoungboyreceivesavaccineatahealthcenterinGlasgow,Scotland.JeffJMitchell/GettyImagesLONDON—Facingagr